I don't know if BioVex' solution to melanoma will prove to be a knockout punch or not, but the results seem to be extremely promising. Too bad TINY's stake in this company is not larger. If this therapy gets commercialized the company may not get to the public market. I could see a large pharma company with a significant presence in oncology making an offer management can't refuse! I am going to e-mail the CEO of BioVex to see if the potential size of the market can be guaged.